Navigation Links
Project aims to reduce complications, multiple surgeries with biodegradable implantable devices
Date:9/4/2008

PITTSBURGHDozens of engineers and doctors from universities and industries around the world will collaborate on a five-year, $18.5 million project announced Sept. 4 to develop implantable devices made from biodegradable metals. The devices will be designed to adapt to physical changes in a patient's body and dissolve once they have healed. Naturally dissolving plates, screws, stents, and other devices would reduce the follow-up surgeries and potential complications of major orthopedic, craniofacial, and cardiovascular proceduressparing millions of patients worldwide added pain and medical expenses.

North Carolina Agricultural and Technical State University (NCAT) will lead the research in partnership with the University of Pittsburgh (Pitt) and the University of Cincinnati (UC). Serving as project director is Jagannathan Sankar, NCAT's Distinguished University Professor of mechanical engineering and director of the Center for Advanced Materials and Smart Structures. Pitt's William Wagner, deputy director of the University's McGowan Institute for Regenerative Medicine and professor of surgery, bioengineering, and chemical engineering, will serve as deputy director along with UC professor Mark Schulz, codirector of the UC Nanoworld and Smart Materials and Devices Laboratories.

The project stems from a five-year Engineering Research Center (ERC) grant NCAT received from the National Science Foundation (NSF) in collaboration with Pitt and UC. The highly competitive ERC grant supports large-scale university and industry collaborations on pioneering technologies considered important to future generations. Five grants were awarded this year from 143 applicants and only 29 universities in the past 25 years have received an ERC. NCAT is the first Historically Black College and University (HCBU) to become an ERC. To coincide with the grant project, NCAT will establish the first bioengineering department at an HCBU with the assistance of faculty members
'/>"/>

Contact: Morgan Kelly
mekelly@pitt.edu
412-624-4356
University of Pittsburgh
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
2. Building a stronger roof over your head: 3 little pigs project begins first tests
3. Caltech researchers awarded $10M for molecular programming project
4. Carbon Disclosure Project, ICLEI partner to help US cities report local climate actions, emissions
5. Life Sciences Discovery Fund awards health research project grants
6. New round of Environmental Venture Projects from Stanfords Woods Institute
7. US Department of Energy Joint Genome Institute announces new genome sequencing projects
8. Early bird project really gets the worm
9. Canada-India RFID project looks to improve traffic flow, reduce pollution
10. Project succeeding to relocate Caspian terns
11. New projects to raise UK profile in synthetic biology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...rofessors recently received funding from the Natio...beneficial to understanding the environment. The t...ood, assistant professor in the Department of Biol... separate research projects. , His first project... and Functions from the Leaf to the Landscape," wi...
(Date:11/24/2009)...escribed by traditional healers in Brazil to treat...in to fever and flu. , Now for the first time, re...o scientifically prove the pain relieving properti...an mint. , Testing this ancient South American he...cha was able to show that when prepared as a ,tea,...
(Date:11/24/2009)...o understanding how sounds associated with Navy so...r if they hear it at all. , The same type of lar...to detect flaws in the space shuttle,s behemoth so...k inside the giant head of a whale. The scans are ... whale,s hearing anatomy using a breakthrough meth...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 1DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 2DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 3DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 4DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 5DOR BioPharma Receives FDA Orphan Drug Designation for orBec 28R 29 for the Treatment of Chronic Gastrointestinal GVHD 13343 6High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 1High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 2High cholesterol in midlife raises risk of late life dementia Kaiser Permanente study finds 53591 3Motorcyclist Lives On Rides On Through Organ Donation 53587 1Motorcyclist Lives On Rides On Through Organ Donation 53587 2Motorcyclist Lives On Rides On Through Organ Donation 53587 3Motorcyclist Lives On Rides On Through Organ Donation 53587 4Motorcyclist Lives On Rides On Through Organ Donation 53587 5
...ray-on films developed by UC San Diego chemists wi...ly reveal trace amounts of nitrogen-based explosiv...s on the films, which glow blue under ultraviolet ...fferent classes of explosive chemicals, a property..., or prevent one. , A recent episode of CSI: Miam...
...ing to a report from a CSIRO Wealth From Oceans Fl...ournal Geophysical Research Letters since 1950 Vi...n rainfall (March to May) compared to the average ...SIROs Dr Wenju Cai and Tim Cowan, say that the dec...s for about half of the total seasonal reduction.,...
... 25, 2008, approaching 5 p.m. PDT, NASA scientists...? , That,s because at that time the Phoenix Mars ... three legs to make a soft landing onto the northe... no valley is actually green on the Red Planet. Th... Mars Reconnaissance Orbiter,s HiRISE instrument. ...
Other Biology News:Glowing films developed by UC San Diego chemists reveal traces of explosives 2Understanding autumn rain decline in SE Australia 2Phoenix mission to Mars will search for climate clues 2Phoenix mission to Mars will search for climate clues 3
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... , SEATTLE, Nov. 24 Blue Marb...nd the Odessa Public Development Authority (OPDA) ...te,s Community Economic Revitalization Board (CERB... state,s first specialty biochemical biorefinery i...l significantly speed the development of our biore...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...BOLZANO, Italy, April 14 Health Robotics today an... 31, 2008, delivering record levels,of firm purcha...Revenues in FY2008 were EUR8.2 million, a 161% inc...d and enjoy the benefits of its indirect,sales-cha...ition, zero debt,financing, worldwide adoption of ...
... Virus-like Particle (VLP) Vaccine Candidate Based...ce and Ferrets Against the Spanish Flu and Highly ...ril 14 /PRNewswire-FirstCall/ -- Novavax, In...udy results showing that an investigational H1N1 v... Spanish influenza strain protected against both t...
...JOSEPH, Mich., April 14 GeneGo, Inc., the leading...at Professor Marcelo Bento Soares of Children,s Me...Stem Cell Partnership Program. The goal of the pr...maps for adult, embryonic, fetal, fibroblasts, hem...pluripotent and totipotent stem cells. , , "We fe...
Other Biology Technology:Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 2Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 3Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 4Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008 5NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 2NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 3NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 4NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 5Children's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2
Hae III (High Concentration) from Takara Mirus Bio
2 ml SmartScan Racks from ABgene
Rabbit Anti-Leptin Receptor Polyclonal Antibody, Unconjugated from BioVision
...wer supply. Capable of producing up to 500 volts a...AGE, SDS-PAGE, DNA or RNA submarine gels as well a... is designed to operate in constant voltage or con...in either mode. The EC135-90 automatically crosses...
Biology Products: